Renaissance Technologies’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Renaissance Technologies’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-61,119	Closed	-$186K	–	3843
2019 Q3	$186K	Sell	61,119 -262,481	-81%	-$738K	﹤0.01%	3166
2019 Q2	$770K	Buy	323,600 +306,200	+1,760%	+$915K	﹤0.01%	2815
2019 Q1	$65K	Buy	+17,400	New	+$65.2K	﹤0.01%	3346
2017 Q3	–	Sell	-154,900	Closed	-$719K	–	3459
2017 Q2	$719K	Buy	154,900 +92,886	+150%	+$415K	﹤0.01%	2669
2017 Q1	$307K	Buy	+62,014	New	+$597K	﹤0.01%	2904
2015 Q3	–	Sell	-100,800	Closed	-$1.03M	–	3465
2015 Q2	$1.03M	Buy	+100,800	New	+$1.11M	﹤0.01%	2434

Other funds holding FOMX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Renaissance Technologies's FOMX Position: Q4 2019 in Review

Renaissance Technologies sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 61,119 shares — an estimated $186K sold.

Renaissance Technologies first reported a position in FOMX in Q2 2015 and held it in 6 quarters. The position peaked at $1.03M in Q2 2015. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

Renaissance Technologies reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
Renaissance Technologies sold 61,119 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $186K.
Renaissance Technologies first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 6 quarters.
Renaissance Technologies's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.03M in Q2 2015.
65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.